
Editorial: gene therapy needs a long-term approach
Gene-therapy trials are on the rise, but more needs to be done to understand the long-term risks associated with this type of treatment.
Gene-therapy trials are on the rise, but more needs to be done to understand the long-term risks associated with this type of treatment.
Increased activity in perivascular fibroblasts could precede motor-neuron degeneration and be a predictor of shorter survival in amyotrophic lateral sclerosis.